Mr. Jim Keon at the Industry, Science and Technology Committee

On April 23rd, 2007. See this statement in context.

April 23rd, 2007 / 4:30 p.m.

President, Canadian Generic Pharmaceutical Association

I think where you find the generic companies developing those products are mainly in the developing world, where they have more access, unfortunately, to the illnesses and more ability to carry out the clinical trials, etc.

It's simply not that practical here to carry out clinical trials on a number of those products.

See context to find out what was said next.